118 related articles for article (PubMed ID: 18489938)
1. Review of side-effect profile of combination ezetimibe and statin therapy in randomized clinical trials.
Kashani A; Sallam T; Bheemreddy S; Mann DL; Wang Y; Foody JM
Am J Cardiol; 2008 Jun; 101(11):1606-13. PubMed ID: 18489938
[TBL] [Abstract][Full Text] [Related]
2. Myopathy induced by statin-ezetimibe combination: Evaluation of potential risk factors.
Brahmachari B; Chatterjee S
Indian J Pharmacol; 2015; 47(5):563-4. PubMed ID: 26600650
[TBL] [Abstract][Full Text] [Related]
3. Ezetimibe monotherapy for cholesterol lowering in 2,722 people: systematic review and meta-analysis of randomized controlled trials.
Pandor A; Ara RM; Tumur I; Wilkinson AJ; Paisley S; Duenas A; Durrington PN; Chilcott J
J Intern Med; 2009 May; 265(5):568-80. PubMed ID: 19141093
[TBL] [Abstract][Full Text] [Related]
4. Management of statin-intolerant patient.
Arca M; Pigna G; Favoccia C
Panminerva Med; 2012 Jun; 54(2):105-18. PubMed ID: 22525565
[TBL] [Abstract][Full Text] [Related]
5. Treating statin-intolerant patients.
Arca M; Pigna G
Diabetes Metab Syndr Obes; 2011; 4():155-66. PubMed ID: 21779147
[TBL] [Abstract][Full Text] [Related]
6. Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes.
Cannon CP; Blazing MA; Giugliano RP; McCagg A; White JA; Theroux P; Darius H; Lewis BS; Ophuis TO; Jukema JW; De Ferrari GM; Ruzyllo W; De Lucca P; Im K; Bohula EA; Reist C; Wiviott SD; Tershakovec AM; Musliner TA; Braunwald E; Califf RM;
N Engl J Med; 2015 Jun; 372(25):2387-97. PubMed ID: 26039521
[TBL] [Abstract][Full Text] [Related]
7. Classical and Novel Lipid-Lowering Therapies for Diabetic Patients with Established Coronary Artery Disease or High Risk of Coronary Artery Disease-A Narrative Clinical Review.
Velidakis N; Stachteas P; Gkougkoudi E; Papadopoulos C; Kadoglou NPE
Pharmaceuticals (Basel); 2024 Apr; 17(5):. PubMed ID: 38794138
[TBL] [Abstract][Full Text] [Related]
8. Severe toxic rhabdomyolysis under combined palbociclib and simvastatin treatment: A case report.
François P; Anna F; Jérémie D; Quentin M; Olivier C; Emmanuelle UC; Céline M; Florence D; Pierre G; Anaïs R
Front Oncol; 2022; 12():1026434. PubMed ID: 36591506
[TBL] [Abstract][Full Text] [Related]
9. Contemporary Management of Dyslipidemia.
Ferraro RA; Leucker T; Martin SS; Banach M; Jones SR; Toth PP
Drugs; 2022 Apr; 82(5):559-576. PubMed ID: 35303294
[TBL] [Abstract][Full Text] [Related]
10. Simvastatin Downregulates Cofilin and Stathmin to Inhibit Skeletal Muscle Cells Migration.
Lin LP; Yu TY; Chang HN; Tsai WC; Pang JS
Int J Mol Sci; 2022 Mar; 23(5):. PubMed ID: 35269994
[TBL] [Abstract][Full Text] [Related]
11. The safety and efficacy of Ezetimibe Plus Statins on ASVD and Related Diseases.
Wan S; Ding Y; Ji X; Meng R
Aging Dis; 2021 Dec; 12(8):1857-1871. PubMed ID: 34881073
[TBL] [Abstract][Full Text] [Related]
12. Is it Time for Single-Pill Combinations in Dyslipidemia?
Schiele F; Pérez de Isla L; Arca M; Vlachopoulos C
Am J Cardiovasc Drugs; 2022 May; 22(3):239-249. PubMed ID: 34549371
[TBL] [Abstract][Full Text] [Related]
13. Bayesian flexible hierarchical skew heavy-tailed multivariate meta regression models for individual patient data with applications.
Kim S; Chen MH; Ibrahim J; Shah A; Lin J
Stat Interface; 2020; 13(4):485-500. PubMed ID: 32855761
[TBL] [Abstract][Full Text] [Related]
14. Independent risk factors for simvastatin-related myopathy and relevance to different types of muscle symptom.
Hopewell JC; Offer A; Haynes R; Bowman L; Li J; Chen F; Bulbulia R; Lathrop M; Baigent C; Landray MJ; Collins R; Armitage J; Parish S
Eur Heart J; 2020 Sep; 41(35):3336-3342. PubMed ID: 32702748
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of Ezetimibe/Simvastatin (10/10 mg) versus High Dose Statin in Dyslipidemia Patients: A Meta-Analysis of Randomized Controlled Trials.
Yang G; Han D; Ma J; Zhang X
Iran J Public Health; 2019 Aug; 48(8):1405-1417. PubMed ID: 32292723
[TBL] [Abstract][Full Text] [Related]
16. Effect of Ephedrae Herba methanol extract on high-fat diet-induced hyperlipidaemic mice.
Lee SE; Lim C; Lim S; Lee B; Cho S
Pharm Biol; 2019 Dec; 57(1):676-683. PubMed ID: 31545933
[No Abstract] [Full Text] [Related]
17. Pharmacological Options in Atherosclerosis: A Review of the Existing Evidence.
Gupta KK; Ali S; Sanghera RS
Cardiol Ther; 2019 Jun; 8(1):5-20. PubMed ID: 30543029
[TBL] [Abstract][Full Text] [Related]
18. Ezetimibe in the Treatment of Patients with Metabolic Diseases.
Nehme MA; Upadhyay A
Eur Endocrinol; 2013 Mar; 9(1):55-60. PubMed ID: 30349611
[TBL] [Abstract][Full Text] [Related]
19. Exploring the In Vivo Anti-Inflammatory Actions of Simvastatin-Loaded Porous Microspheres on Inflamed Tenocytes in a Collagenase-Induced Animal Model of Achilles Tendinitis.
Jeong C; Kim SE; Shim KS; Kim HJ; Song MH; Park K; Song HR
Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29534523
[TBL] [Abstract][Full Text] [Related]
20. Effect of Low-Density Lipoprotein Cholesterol Lowering by Ezetimibe/Simvastatin on Outcome Incidence: Overview, Meta-Analyses, and Meta-Regression Analyses of Randomized Trials.
Thomopoulos C; Skalis G; Michalopoulou H; Tsioufis C; Makris T
Clin Cardiol; 2015 Dec; 38(12):763-9. PubMed ID: 26282344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
